RESUMO
ObjectiveTo screen the risk factors of osteoporosis in perimenopausal women, and to provide direction for timely prevention and treatment. MethodsUsing multilevel stratified random sampling method, the perimenopausal women were investigated by questionnaire survey, and the determination of bone mineral density (BMD) and the levels of several important hormones. ResultsA total of 720 valid questionnaires were received. Among 720 perimenopausal women, 173 had osteoporosis and 547 had no osteoporosis. Univariate analysis of the influencing factors of osteoporosis showed that the levels of parathyroid hormone (PTH), Estradiol (E2), body mass index (BMI), age, time of last period and age of menopause were significantly different among perimenopausal women in the prevalence of osteoporosis(χ2=4.23, 4.86, 16.06, 21.04, 10.52, 13.02; P<0.05).Logistic regression analysis showed that the increase of PTH (OR=2.70, P<0.05)and menopause (OR=1.76, P<0.05) were the risk factors of osteoporosis . Higher BMI(OR=0.65, P<0.05), higher personal monthly income(OR=0.72, P<0.05), longer sunshine time(OR=0.69, P<0.05), were the protective factors against osteoporosis. ConclusionThe increase of PTH levels and menopause are the risk factors for osteoporosis in women. Perimenopausal women should be monitored for bone mineral density and appropriate intervention. Necessary treatment measures should be taken for the patients with osteopenia and osteoporosis.
RESUMO
BACKGROUND: Prior research has confirmed the efficacy of exercise training (ET) in patients with prediabetes. However, whether the effectiveness of a combination of exercise and psychological intervention (EP) is better than ET alone in prediabetes in terms of physiological function, psychological status and glycometabolism has rarely been investigated. METHODS: Forty newly diagnosed prediabetes patients (65.3 ± 8.1 years) took part in the study. Subjects were divided into a pure ET group and a combined EP group. Interventions were conducted in 40-50-min sessions twice weekly for 32 weeks. Physiological, psychological and biochemical indicator measurements were taken after pre-, mid- and post-interventions, respectively. RESULTS: The main finding confirmed a significant improvement in systolic blood pressure, diastolic blood pressure (DBP) and heart rate, high-density lipoprotein, fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) from pre- to mid- and post-test differentially in both groups (P < 0.05) by post hoc analyses. The EP group has a greater magnitude of improvement of DBP than the ET group. Significant differences were observed in FPG at mid-intervention and total cholesterol at post-intervention between the ET and EP groups. Self-Rating Anxiety Scale (SAS) scores of EP group were significantly less than ET group after post-intervention. CONCLUSION: Our results suggest that EP might be a promising method lead to more apparent long-term effects on glycometabolism and psychological status for prediabetes patients. Other domains were improved by both interventions, but no typical pattern could be identified. Its underlying mechanisms need further study, and directions for future research are suggested.